Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
Pablo Corral/LinkedIn
Nov 3, 2025, 08:57

Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy

 

Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, posted on LinkedIn:

”New in ATVB (Nov 2025)

Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy

In >11,800 post-ACS patients from ODYSSEY OUTCOMES, a 9-plex mass-spectrometry apolipoprotein panel outperformed the standard lipid profile in predicting:
• Major adverse cardiovascular events (MACE) (AUC 0.65 vs 0.58)
• All-cause death (AUC 0.70 vs 0.60)

The panel also identified which patients benefit most from PCSK9 inhibition (alirocumab) – paving the way for precision lipidology.

Key components: Apo(a), ApoA-I, ApoA-II, ApoA-IV, ApoB, ApoC-I, ApoC-II, ApoC-III, ApoE.

Alirocumab reduced Apo(a), ApoB, and ApoC isoforms by >30–50%.

Bottom line:
Integrated apolipoprotein profiling refines risk stratification and optimizes treatment allocation – a step forward in personalized cardiovascular medicine.

Open Access”

Title: Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy

Authors: Esther Reijnders, Patrick M. Bossuyt, J. Wouter Jukema, L. Renee Ruhaak, Fred P.H.T.M. Romijn, Michael Szarek, Stella Trompet, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, Sergio Fazio, Irena Stevanovic, Shaun G. Goodman, Robert A. Harrington, Harvey D. White, Philippe Gabriel Steg, Gregory G. Schwartz, Christa M. Cobb

Apolipoprotein

Stay informed with Hemostasis Today.

Alirocumab Apolipoprotein Cardiology Cardiovascular Event Prediction Cardiovascular Outcome cardiovascular risk Christa M. Cobb Deepak L Bhatt Esther Reijnders FASTA Universit Fred P.H.T.M. Romijn Gregory G. Schwartz Harvey D. White Health Heart Health Hematology Hemostasis Hemostasis Today Irena Stevanovic J. Wouter Jukema L. Renee Ruhaak Lipidology Medicine Michael Szarek Pablo Corral Patrick M. Bossuyt PCSK9 Inhibitor Therapy Philippe Gabriel Steg Rafael Diaz Robert A. Harrington Sergio Fazio Shaun G. Goodman Stella Trompet thrombosis Vera A. Bittner
NewsFeed